Stockholders' Equity (Details Narrative) - USD ($) |
3 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 27, 2019 |
Nov. 15, 2019 |
Jul. 19, 2019 |
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2019 |
|
| Common stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||
| Common stock, issued during the period, value | $ 474,808 | $ 7,472,417 | $ 385,117 | |||
| Common stock percent | 3.00% | |||||
| Professional fees | $ 25,000 | $ 146,642 | $ 85,033 | |||
| Common stock issued during period | 1,058,558 | |||||
| Preferred stock, shares outstanding | ||||||
| Series B Convertible Preferred Stock [Member] | ||||||
| Preferred stock, shares outstanding | ||||||
| Series E Convertible Preferred Stock [Member] | ||||||
| Preferred stock, shares outstanding | ||||||
| Market Offering [Member] | ||||||
| Common stock issued during period | 403,075 | |||||
| Net proceeds | $ 401,891 | |||||
| Net of offering cost | $ 16,774 | |||||
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Purchase price of common stock expressed as a percentage of its fair value. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|